meldepliktige handler fra primærinnsidere

← Alle transaksjoner

Management in Medistim ASA purchases shares

Medistim ASA (MEDI) · publisert 13. november 2023 kl. 15:09 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplassTolket via
Roger Morberg VP sales APACacquisition3 410161,67 NOK13. november 2023llm
Ole Arne Eiksund Chief Business Development Officeracquisition3 410161,67 NOK13. november 2023llm
Ole Jørgen Robsrud CEO in Medistim Norge ASacquisition1 237161,67 NOK13. november 2023llm
Hæge Wetterhus VP Marketingacquisition928161,67 NOK13. november 2023llm
Stephanie Stenhagen VP Sales EMEAacquisition247161,67 NOK13. november 2023llm
Håkon Grøthe VP Innovationacquisition3 410161,67 NOK13. november 2023llm
Thomas Jakobsen CFOacquisition4 547161,67 NOK13. november 2023llm

Meldingstekst

Management in Medistim ASA has the 13th of November purchased shares form Medistim ASA. This is part of the company long term incentive plan approved by the general meeting the 24th of April 2023. Price per share was NOK 161,67. The following members of management has purchased shares: VP sales APAC Roger Morberg purchased 3410 shares and has 16259 shares after the purchase. Chief Business Development Officer Ole Arne Eiksund purchased 3410 shares and has 5872 shares after the purchase. CEO in Medistim Norge AS Ole Jørgen Robsrud purchased 1237 shares and has 3442 shares after the purchase. VP Marketing Hæge Wetterhus purchased 928 shares and has 1591 shares after the purchase. VP Sales EMEA Stephanie Stenhagen purchased 247 shares and has 557 shares after the purchase. VP Innovation Håkon Grøthe purchased 3410 shares and has 7821 shares after the purchase. CFO Thomas Jakobsen purchased 4547 shares and has 30526 shares after the purchase. Medistim ASA has sold 17189 shares and has 57843 own shares after the sale.